Img header logo

GRI Standards Content Index

ONO PHARMACEUTICAL CO.,LTD., ONO PHARMACEUTICAL CO.,LTD., system

GRI Standards Content Index

Our website refers to the Global Reporting Initiative (GRI) Standards.The descriptions are shown in this comparative table.

General Disclosures
Disclosure Number Description References/Response
1. Organizational profile
102-1 Name of the organization
  1. Company Profile
102-2 Activities, brands, products, and services
  1. Main Products
102-3 Location of headquarters
  1. Business Locations
102-4 Location of operations
  1. Business Locations
102-5 Ownership and legal form
  1. Company Profile
102-6 Markets served
  1. Global Business
102-7 Scale of the organization
  1. Company Profile
  1. Business Locations
  1. Financial Highlights
  1. Main Products
102-8 Information on employees and other workers
  1. Social Data
102-9 Supply chain
  1. Supply Chain Management
102-11 Precautionary Principle or approach
  1. Risk Management
  1. Information Disclosure Based on the TCFD Recommendation
  1. Our Materiality
102-12 External initiatives
  1. Participation in the United Nations Global Compact
  1. Environmental Initiatives
    (the United Nations Global Compact,Science Based Targets initiative,Task Force on Climate-related Financial Disclosures,Renewable Energy 100%)
102-13 Membership of associations
  1. The Federation of Pharmaceutical Manufacturers’ Associations of JAPAN,Japan Pharmaceutical Manufacturers Association,KEIDANREN (Japan Business Federation),Kansai Pharmaceutical Industries Association,etc.
2. Strategy
102-14 Statement from senior decision-maker
  1. Top message
  1. Corprate Report: Top message(PP.11-16)
102-15 Key impacts, risks, and opportunities
  1. Our Materiality
3. Ethics and integrity
102-16 Values, principles, standards, and norms of behavior
  1. Mission Statement
102-17 Mechanisms for advice and concerns about ethics
  1. Compliance
4. Governance
102-18 Governance structure
  1. Corporate Governance
102-19 Delegating authority
  1. CSR Promotion Structure
  1. Promotion of Environmental Management
102-20 Executive-level responsibility for economic, environmental, and social topics
  1. CSR Promotion Structure
102-21 Consulting stakeholders on economic, environmental, and social topics
  1. Stakeholder engagement
102-22 Composition of the highest governance body and its committees
  1. Corporate Governance Report(PP.9-19)
102-23 Chair of the highest governance body
  1. Corporate Governance Report(PP.9-19)
102-24 Nominating and selecting the highest governance body
  1. Corporate Governance Report(PP.9-19)
102-25 Conflicts of interest
  1. Corporate Governance Report(PP.9-19)
102-28 Evaluating the highest governance body’s performance
  1. Corporate Governance Report(PP.1-8)
  1. Information Disclosure Based on the TCFD Recommendation
102-29 Identifying and managing economic, environmental, and social impacts
  1. Corporate Governance Structure
  1. Risk Management
102-30 Effectiveness of risk management processes
  1. Corporate Governance Structure
  1. Risk Management
102-31 Review of economic, environmental, and social topics
  1. ONO's Approach to Sustainability
102-32 Highest governance body’s role in sustainability reporting
  1. ONO's Approach to Sustainability
  1. CSR Promotion Structure
102-33 Communicating critical concerns
  1. Corporate Governance Structure
102-34 Nature and total number of critical concerns
  1. Corporate Governance Structure
  1. Risk Management
102-35 Remuneration policies
  1. Corporate Governance Report(PP.9-19)
102-36 Process for determining remuneration
  1. Corporate Governance Report(PP.9-19)
102-37 Stakeholders’ involvement in remuneration
  1. Corporate Governance Report(PP.9-19)
5. Stakeholder engagement
102-40 List of stakeholder groups
  1. Stakeholder engagement
102-41 Collective bargaining agreements
  1. Social Data
102-43 Approach to stakeholder engagement
  1. Stakeholder engagement
6. Reporting practice
102-45 Entities included in the consolidated financial statements
  1. Corporate Report
    Corporate Information / Stock Information
102-46 Defining report content and topic Boundaries
  1. ONO's Approach to Sustainability
102-47 List of material topics
  1. Our Materiality
102-49 Changes in reporting
  1. Our Materiality
102-50 Reporting period
  1. Sustainability Report 2022 (P.2):FY2021 (from April 2021 to March 2022)
  1. Corporate Report 2022 (P.3):FY2022 (from April 1, 2021 to March 31, 2022)
102-51 Date of most recent report
  1. Sustainability Report 2022 (P.2):October 2022
  1. Corporate Report 2022 (P.3):September 2022
102-52 Reporting cycle
  1. WEB:Update as needed
  1. Sustainability Report, Corporate Report :Annual
102-53 Contact point for questions regarding the report
  1. Contact
102-55 GRI content index
  1. GRI Standards Comparative Table
102-56 External assurance
  1. Independent Practitioner's Assurance
GRI 103: Management Approach 2016
103-1 Explanation of the material topic and its Boundary
  1. Our Materiality
  1. Risk Management
103-2 The management approach and its components
  1. ONO's Approach to Sustainability
  1. Risk Management
103-3 Evaluation of the management approach
  1. Our Materiality
Economic topics
Disclosure Number Description Reference/Response
GRI 201: Economic Performance 2016
201-1 Direct economic value generated and distributed
  1. Financial Highlights
  1. Social Contribution Activities
201-2 Financial implications and other risks and opportunities due to climate change
  1. Information Disclosure Based on the TCFD Recommendation
  1. Risk Management
GRI 203: Indirect Economic Impacts 2016
203-1 Infrastructure investments and services supported
  1. Efforts Made for Improving Access to Healthcare
GRI 205: Anti-corruption 2016
205-1 Operations assessed for risks related to corruption
  1. Ono Pharmaceutical Global Anti-Bribery and Corruption Policy
205-2 Communication and training about anti-corruption policies and procedures
  1. Governance Data
205-3 Confirmed incidents of corruption and actions taken
  1. Governance Data
  1. Compliance
  1. Notice of Convocation for The 74th Ordinary General Shareholders’ Meeting(P.11)
GRI 207: Tax 2019
207-1 Approach to tax
  1. Ono Pharmaceutical Global Tax Policy
207-2 Tax governance, control, and risk management
  1. Compliance Promotion Initiatives
207-3 Stakeholder engagement and management of concerns related to tax
  1. Ono Pharmaceutical Global Tax Policy
207-4 Country-by-country reporting
  1. Tax Reporting by Country
Environmental topics
Disclosure Number Description Reference/Response
GRI 302: Energy 2016
302-1 Energy consumption within the organization
  1. Environmental Data
  1. Realization of a Decarbonized Society
302-4 Reduction of energy consumption
  1. Realization of a Decarbonized Society
GRI 303: Water and Effluents 2018
303-1 Interactions with water as a shared resource
  1. Realization of a Water Recycling-oriented Society
303-2 Management of water discharge-related impacts
  1. Biodiversity Conservation
303-3 Water withdrawal
  1. Realization of a Water Recycling-oriented Society
303-4 Water discharge
  1. Realization of a Water Recycling-oriented Society
303-5 Water consumption
  1. Water consumption for our company can be calculated as follows: Amount of water intake - Amount of wastewater = Amount of water consumption.
GRI 304: Biodiversity 2016
304-1 Operational sites owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas
  1. Business Locations
304-2 Significant impacts of activities, products, and services on biodiversity
  1. Biodiversity Conservation
304-3 Habitats protected or restored
  1. Biodiversity Conservation
GRI 305: Emissions 2016
305-1 Direct (Scope 1) GHG emissions
  1. Environmental Data
  1. Targets (Medium- to Long-term Targets and Fiscal Year Targets) and Results
305-2 Energy indirect (Scope 2) GHG emissions
  1. Environmental Data
  1. Targets (Medium- to Long-term Targets and Fiscal Year Targets) and Results
305-3 Other indirect (Scope 3) GHG emissions
  1. Environmental Data
  1. GHG Emissions in the Value Chain (Scope 3)
305-5 Reduction of GHG emissions
  1. Realization of a Decarbonized Society
305-7 Nitrogen oxides (NOX), sulfur oxides (SOX), and other significant air emissions
  1. Environmental Data
  1. Reduction of Environmental Risks
GRI 306: Waste 2020
306-2 Management of significant wasterelated impacts
  1. Realization of a Resource Recycling Society
306-3 Waste generated
  1. Environmental Data
  1. Realization of a Resource Recycling Society
306-4 Waste diverted from disposal
  1. Environmental Data
  1. Realization of a Resource Recycling Society
306-5 Waste directed to disposal
  1. Environmental Data
  1. Realization of a Resource Recycling Society
GRI 307: Environmental Compliance 2016
307-1 Non-compliance with environmental laws and regulations
  1. Environmental Data
Social topics
Disclosure Number Description Reference/Response
GRI 401: Employment 2016
401-1 New employee hires and employee turnover
  1. Social Data
401-2 Benefits provided to full-time employees that are not provided to temporary or part-time employees
  1. Promoting the Creation of an Employee-friendly Working Environment
GRI 403: Occupational Health and Safety 2018
403-1 Occupational health and safety management system
  1. Promoting the Creation of an Employee-friendly Working Environment(Safety and Health)
403-2 Hazard identification, risk assessment, and incident investigation
  1. Promoting the Creation of an Employee-friendly Working Environment(Safety and Health)
403-3 Occupational health services
  1. Promoting the Creation of an Employee-friendly Working Environment(Safety and Health)
403-4 Worker participation, consultation, and communication on occupational health and safety
  1. Promoting the Creation of an Employee-friendly Working Environment(Safety and Health)
403-6 Promotion of worker health
  1. Organizational Structure to Promote Health Management
403-9 Work-related injuries
  1. Social Data
  1. Promoting the Creation of an Employee-friendly Working Environment
403-10 Work-related ill health
  1. Social Data
  1. Promoting the Creation of an Employee-friendly Working Environment
GRI 404: Training and Education 2016
404-2 Programs for upgrading employee skills and transition assistance programs
  1. Talent Development
404-3 Percentage of employees receiving regular performance and career development reviews
  1. Promoting the Creation of an Employee-friendly Working Environment
All employees have semi-annual goal-setting and evaluation feedback interviews.Implementation rate (Male: 100%, female: 100%)
GRI 405: Diversity and Equal Opportunity 2016
405-1 Diversity of governance bodies and employees
  1. Social Data
  1. Governance Data
  1. Promotion of Diversity and Inclusion
GRI 406: Non-discrimination 2016
406-1 Incidents of discrimination and corrective actions taken
  1. Governance Data
GRI 412: Human Rights Assessment 2016
412-2 Employee training on human rights policies or procedures
  1. Governance Data
  1. Compliance Promotion Initiatives
GRI 413: Local Communities 2016
413-1 Operations with local community engagement, impact assessments, and development programs
  1. Efforts at Each Worksite
GRI 416: Customer Health and Safety 2016
416-1 Assessment of the health and safety impacts of product and service categories
  1. Manufacturing
  1. Safety and Quality Assurance
GRI 417: Marketing and Labeling 2016
417-1 Requirements for product and service information and labeling
  1. Realization of a Resource Recycling Society
417-3 Incidents of non-compliance concerning marketing communications
  1. For the Materiality Targets and Progress / Implementation of Responsible Marketing and Promotion Activities
GRI 419: Socioeconomic Compliance 2016
419-1 Non-compliance with laws and regulations in the social and economic area
  1. Governance Data
  1. Our Materiality
ONO PHARMACEUTICAL CO.,LTD., ONO PHARMACEUTICAL CO.,LTD., system